Clinical Trial Update: Atamparib in Patients With Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for Atamparib in patients with advanced solid tumors, including non-small cell lung cancer with adenocarcinoma histology, in a Phase 1/2 s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Atamparib (Atamparib)

Snippet

Sponsor: Nerviano Medical Sciences (Shanghai) Ltd. | Conditions: NSCLC Adenocarcinoma, Solid Tumor | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING